|

taxane drug Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1

Indications

  • HER2-positive Metastatic Breast Cancer1
  • First Line Treatment1
  • Breast Cancer1
  • Cancer1

Other1 trial

Disitamab Vedotin + Pyrotinib Versus THP in the First-line Treatment for HER2+ Advanced Breast Cancer Clinical Trial
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.